Metabolomics Analysis of Collagen-induced Arthritis in Rats and Interventional Effects of Oral Tolerance

Analytical Biochemistry

Volumn 458, Issue , 2014, Pages 49-57

  Ding, Xinghong ^a   Hu, Jinbo ^a   Li, Jinfeng ^a   Zhang, Yan ^a   Shui, Bingjie ^a   Ding, Zhishan ^a   Yao, Li ^a   Fan, Yongsheng ^a  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Collagen induced arthritis; Metabolomics; PLS DA; Rheumatoid arthritis; RRLC Q TOF MS

Indexed keywords

ASCORBIC ACID; COLLAGEN; DISCRIMINANT ANALYSIS; LEAST SQUARES APPROXIMATIONS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLITES; PHOSPHOLIPIDS; RATS;

CARDIOVASCULAR DISEASE; COLLAGEN-INDUCED ARTHRITIS; HISTOPATHOLOGICAL ANALYSIS; HOLISTIC EVALUATIONS; METABOLIC SYNDROMES; PARTIAL LEAST SQUARES DISCRIMINANT ANALYSES (PLSDA); QUADRUPOLE TIME OF FLIGHT MASS SPECTROMETRY; RAPID RESOLUTION LIQUID CHROMATOGRAPHIES;

DISEASES;

ARACHIDONIC ACID; COLLAGEN TYPE 2; PHOSPHOLIPID;

ANIMAL; ARTHRITIS, EXPERIMENTAL; BLOOD; CLUSTER ANALYSIS; DISCRIMINANT ANALYSIS; DISEASE MODEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLISM; METABOLOME; METABOLOMICS; PATHOLOGY; RAT; REGRESSION ANALYSIS; WISTAR RAT;

ANIMALS; ARACHIDONIC ACID; ARTHRITIS, EXPERIMENTAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLUSTER ANALYSIS; COLLAGEN TYPE II; DISCRIMINANT ANALYSIS; DISEASE MODELS, ANIMAL; LEAST-SQUARES ANALYSIS; MALE; METABOLOME; METABOLOMICS; PHOSPHOLIPIDS; RATS; RATS, WISTAR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84922391466     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2014.04.035     Document Type: Article

References (34)

1. Feuchtenberger, M., Kleinert, S., Schwab, S., Roll, P., Scharbatke, E.C., Ostermeier, E., Voll, R.E., Schäfer, A., Tony, H.-P., Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study. Rheumatology international 32 (2012), 1533–1539.
2. Müller-Ladner, U., Pap, T., Gay, R.E., Neidhart, M., Gay, S., Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis. Nature clinical practice Rheumatology 1 (2005), 102–110.
3. H. Yamanaka, Y. Seto, E. Tanaka, T. Furuya, A. Nakajima, K. Ikari, A. Taniguchi, and S. Momohara, Management of rheumatoid arthritis: the 2012 perspective. Modern Rheumatology 23 (2013) 1-7.
4. Faria, A., Weiner, H.L., Oral tolerance: mechanisms and therapeutic applications. Advances in immunology 73 (1999), 153–264.
5. Kim, H.Y., Kim, W.U., Cho, M.L., Lee, S.K., Youn, J., Kim, S.I., Yoo, W.H., Park, J.H., Min, J.K., Lee, S.H., Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255–274) in patients with rheumatoid arthritis. Arthritis & Rheumatism 42 (1999), 2085–2093.
6. M.L. Barnett, J. Kremer, E. St Clair, D. Clegg, D. Furst, M. Weisman, M. Fletcher, S. Chasan-Taber, E. Finger, and A. Morales, Treatment of rheumatoid arthritis with oral type II collagen. Arthritis Rheum 41 (1998) 290-297.
7. Park, K.-S., Park, M.-J., Cho, M.-L., Kwok, S.-K., Ju, J.H., Ko, H.-J., Park, S.-H., Kim, H.-Y., Type II collagen oral tolerance; mechanism and role in collagen-induced arthritis and rheumatoid arthritis. Modern Rheumatology 19 (2009), 581–589.
8. Nicholson, J.K., Lindon, J.C., Holmes, E., ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29 (1999), 1181–1189.
9. Vuckovic, D., Current trends and challenges in sample preparation for global metabolomics using liquid chromatography–mass spectrometry. Analytical and bioanalytical chemistry 403 (2012), 1523–1548.
10. Weckwerth, W., Metabolomics in systems biology. Annual review of plant biology 54 (2003), 669–689.
11. An, Z., Chen, Y., Zhang, R., Song, Y., Sun, J., He, J., Bai, J., Dong, L., Zhan, Q., Abliz, Z., Integrated Ionization Approach for RRLC− MS/MS-based Metabonomics: Finding Potential Biomarkers for Lung Cancer. Journal of Proteome Research 9 (2010), 4071–4081.
12. Tong, T., Zhao, W., Wu, Y.-Q., Chang, Y., Wang, Q.-T., Zhang, L.-L., Wei, W., Chicken type II collagen induced immune balance of main subtype of helper T cells in mesenteric lymph node lymphocytes in rats with collagen-induced arthritis. Inflammation Research 59 (2010), 369–377.
13. Bijlsma, S., Bobeldijk, I., Verheij, E.R., Ramaker, R., Kochhar, S., Macdonald, I.A., van Ommen, B., Smilde, A.K., Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Analytical Chemistry 78 (2006), 567–574.
14. Smith, C.A., O'Maille, G., Want, E.J., Qin, C., Trauger, S.A., Brandon, T.R., Custodio, D.E., Abagyan, R., Siuzdak, G., METLIN: a metabolite mass spectral database. Therapeutic drug monitoring 27 (2005), 747–751.
15. Wishart, D.S., Knox, C., Guo, A.C., Eisner, R., Young, N., Gautam, B., Hau, D.D., Psychogios, N., Dong, E., Bouatra, S., HMDB: a knowledgebase for the human metabolome. Nucleic acids research 37 (2009), D603–D610.
16. Kanehisa, M., Goto, S., KEGG: kyoto encyclopedia of genes and genomes. Nucleic acids research 28 (2000), 27–30.
17. Piomelli, D., Arachidonic acid in cell signaling. Current opinion in cell biology 5 (1993), 274–280.
18. Hegen, M., Sun, L., Uozumi, N., Kume, K., Goad, M.E., Nickerson-Nutter, C.L., Shimizu, T., Clark, J.D., Cytosolic Phospholipase A2α–deficient Mice Are Resistant to Collagen-induced Arthritis. The Journal of experimental medicine 197 (2003), 1297–1302.
19. Harris, W.S., Mozaffarian, D., Rimm, E., Kris-Etherton, P., Rudel, L.L., Appel, L.J., Engler, M.M., Engler, M.B., Sacks, F., Omega-6 fatty acids and risk for cardiovascular disease a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 119 (2009), 902–907.
20. Pommery, J., Pommery, N., Hénichart, J.-P., Modification of eicosanoid profile in human blood treated by dual COX/LOX inhibitors. Prostaglandins, leukotrienes and essential fatty acids 73 (2005), 411–417.
21. M. Manuela Rosado, A. Picchianti Diamanti, F. Capolunghi, and R. Carsetti, B cell modulation strategies in autoimmunity: the SLE example. Current pharmaceutical design 17 (2011) 3155-3165.
22. Di Mari, J.F., Saada, J.I., Mifflin, R.C., Valentich, J.D., Powell, D.W., HETEs enhance IL-1-mediated COX-2 expression via augmentation of message stability in human colonic myofibroblasts. American Journal of Physiology-Gastrointestinal and Liver. Physiology 293 (2007), G719–G728.
23. Strassburg, K., Huijbrechts, A.M., Kortekaas, K.A., Lindeman, J.H., Pedersen, T.L., Dane, A., Berger, R., Brenkman, A., Hankemeier, T., Van Duynhoven, J., Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: application in cardiac surgery. Analytical and bioanalytical chemistry 404 (2012), 1413–1426.
24. Caughey, G.E., James, M.J., Proudman, S.M., Cleland, L.G., Fish oil supplementation increases the cyclooxygenase inhibitory activity of paracetamol in rheumatoid arthritis patients. Complementary therapies in medicine 18 (2010), 171–174.
25. S. Manzi, and M.C.M. WASKO, Inflammation-mediated rheumatic diseases and atherosclerosis. Annals of the rheumatic diseases 59 (2000) 321–325.
26. Hasunuma, T., Kato, T., Kobata, T., Nishioka, K., Molecular mechanism of immune response, synovial proliferation and apoptosis in rheumatoid arthritis. 1998, Springer, Springer seminars in immunopathology pp. 41–52.
27. K. Mayer, C. Fegbeutel, K. Hattar, U. Sibelius, H.-J. Krämer, K.-U. Heuer, B. Temmesfeld-Wollbrück, S. Gokorsch, F. Grimminger, and W. Seeger, ω-3 vs. ω-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation. Intensive care medicine 29 (2003) 1472–1481.
28. Liu, R., Metabolomic Study of Collagen-Induced Arthritis in Rats and the Interventional Effects of Huang-Lian-Jie-Du-Tang, a Traditional Chinese Medicine. Evidence-Based Complementary and Alternative Medicine, 2013, 2013.
29. McMurray, H.F., Parthasarathy, S., Steinberg, D., Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. Journal of Clinical Investigation, 92, 1993, 1004.
30. Ajeganova, S., Ehrnfelt, C., Alizadeh, R., Rohani, M., Jogestrand, T., Hafström, I., Frostegård, J., Longitudinal levels of apolipoproteins and antibodies against phosphorylcholine are independently associated with carotid artery atherosclerosis 5 years after rheumatoid arthritis onset—a prospective cohort study. Rheumatology 50 (2011), 1785–1793.
31. Charles-Schoeman, C., Cardiovascular disease and rheumatoid arthritis: an update. Current rheumatology reports 14 (2012), 455–462.
32. E.S. Ford, W.H. Giles, and W.H. Dietz, Prevalence of the metabolic syndrome among US adults. JAMA: the journal of the American Medical Association 287 (2002) 356–359.
33. Chung, C.P., Oeser, A., Solus, J.F., Avalos, I., Gebretsadik, T., Shintani, A., Raggi, P., Sokka, T., Pincus, T., Stein, C.M., Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 196 (2008), 756–763.
34. Frostegård, J., Atherosclerosis and Cardiovascular Disease in Rheumatoid Arthritis. The Journal of rheumatology 39 (2012), 2233–2234.